Although we had previously shown that knockdown of RRAS2 expression in the human triple negative breast cancer cell line MDA-MB231 was required for tumor generation in experiments of xenograft [47], we aimed to reinforce those data by incorporating three additional human cancer cell lines of different types. The gene discussed is RRAS2; the disease is triple-negative breast carcinoma.